Trials / Completed
CompletedNCT00972738
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
A Multi-Center, Double-blind, Randomized, Parallel-Group Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Spring 2001 Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,214 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the treatment effect of montelukast versus placebo over a 2 week period in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Montelukast 10-mg tablet orally once daily at bedtime for 2 weeks. |
| DRUG | Comparator: loratadine | Loratadine 10-mg tablet orally once daily at bedtime for 2 weeks. |
| DRUG | Comparator: Placebo | placebo tablet orally once daily at bedtime for 2 weeks |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2001-07-01
- Completion
- 2001-07-01
- First posted
- 2009-09-07
- Last updated
- 2022-02-03
- Results posted
- 2010-06-16
Source: ClinicalTrials.gov record NCT00972738. Inclusion in this directory is not an endorsement.